The Asia-Pacific (APAC) gene therapy market is growing on account of the increasing research and development (R&D) activities in this field, many of which are yielding positive clinical trial results, and rising incidence of chronic diseases. Because of these factors, the market generated revenue of $349.1 million in 2020, and it will grow at a 36.8% CAGR between 2021 and … Continua a leggere→